Golnaz Zaeri, Project Coordinator at Iranian Society of Clinical Oncology, shared an update from Iranian Society of Clinical Oncology, on LinkedIn, adding:
“Excited to be managing this upcoming tumor board on HER2-positive breast cancer with the Iranian Society of Clinical Oncology.”
Quoting Iranian Society of Clinical Oncology:
“HER2-Positive Breast Cancer Tumor Board. From Case to Decision
A multidisciplinary and interactive review of submitted clinical cases, focusing on real-world clinical decision-making. CME Accredited.
One Case. Multiple Perspectives. Better Decisions.”
This also can be interesting: HER2-Positive Breast Cancer: From Fear to a Story of Hope
